Evidence map›Paper›PMID 32543746›Full record

ArticleGenesis (New York, N.Y. : 2000)2020

Reporter mice for isolating and auditing cell type-specific extracellular vesicles in vivo.

James V McCann, Steven R Bischoff, Yu Zhang, Dale O Cowley, Veronica Sanchez-Gonzalez, George D Daaboul, Andrew C Dudley

Abstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Exosome: an overview on enhanced biogenesis by small molecules.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency.Molecular therapy. Methods & clinical development · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Exomap1 mouse: A transgenic model forExtracellular vesicle · 2023
    Article
  18. Review
  19. Article
  20. The Machinery of Exosomes: Biogenesis, Release, and Uptake.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James V McCannDepartment of Cell Biology & Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Steven R BischoffAnimal Models Core, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9287-7250
Yu ZhangDepartment of Microbiology, Immunology, and Cancer Biology, The University of Virginia, Charlottesville, Virginia, USA.
Dale O CowleyAnimal Models Core, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Veronica Sanchez-GonzalezNanoView Biosciences, Brighton, Massachusetts, USA.
George D DaaboulNanoView Biosciences, Brighton, Massachusetts, USA.
Andrew C DudleyDepartment of Microbiology, Immunology, and Cancer Biology, The University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-2663-1949

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jay William FOX · 1987 to 2026
$72.1M
Targeting the vasculature to enhance anti-tumor immunityR01CA177875 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Andrew Carl Dudley · 2014 to 2026
$4.5M
A microRNA mediating vascular directed fibrinolysis and tumor progressionF31CA213793 · NCI · UNIVERSITY OF VIRGINIA · PI MCCANN, JAMES V · 2017 to 2019
$95k
NCI NIH HHS F31 CA213793NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA177875NCI NIH HHS RO1-CA177874
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are abundant, lipid-enclosed vectors that contain nucleic acids and proteins, they can be secreted from donor cells and freely circulate, and they can be engulfed by recipient cells thus enabling systemic communication between heterotypic cell types. However, genetic tools for labeling, isolating, and auditing cell type-specific EVs in vivo, without prior in vitro manipulation, are lacking. We have used CRISPR-Cas9-mediated genome editing to generate mice bearing a CD63-emGFP

Indexed as

AnimalsCells, CulturedCRISPR-Cas SystemsEndothelium, VascularExtracellular VesiclesGene Knock-In TechniquesGreen Fluorescent ProteinsHEK293 CellsHumansIntegrasesMiceMice, Inbred C57BLTetraspanin 30Cre recombinaseGreen Fluorescent ProteinsIntegrasesTetraspanin 30angiogenesiscancerendothelial lineage tracingexosomesextracellular vesiclestumor microenvironment

Identifiers

PMID32543746
PMCPMC7405599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.